June 26, 2025 at 7:22 pm
Ambusol AB (publ) has held an Extraordinary General Meeting where shareholders resolved to authorize the Board of Directors to issue new shares to strengthen the company’s capital base ahead of upcoming clinical studies. All resolutions were passed in accordance with the Board’s proposals.